Rep. Miller’s Legislation Would Reinstate Safety Regulations on Dangerous Abortion Pill

FOR IMMEDIATE RELEASE

WASHINGTON, D.C. - Congresswoman Mary Miller's (IL-15) Restoring Safeguards for Dangerous Abortion Drugs Act comes following Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.'s announcement of a new review of abortion pills such as mifepristone.

This legislation aims to reinstate in-person medical requirements for mifepristone. As the House companion to Senator Josh Hawley's (R-MO) measure, the bill would end the mail-order distribution of abortion drugs, which are now used in nearly two-thirds of all abortions in the United States.

A landmark study, reviewing more than 865,000 chemical abortions, has revealed that the risksof the abortion pill are far greater than the U.S. Food and Drug Administration (FDA) admits. The study found that nearly 11% of women who take mifepristone suffer serious complications within 45 days, including sepsis, infection, hemorrhaging, or an emergency room visit. This complication rate is at least 22 times higherthan the less than 0.5% adverse event rate listed on the FDA-approved drug label.

"Chemical abortion drugs are dangerous, and women are suffering life-threatening complications because critical safeguards were recklessly removed," said Congresswoman Mary Miller. "It is time to restore commonsense protections, guarantee adequate medical care for women, and hold Big Abortion accountable for putting profit over safety."

Mifepristone was first approved by the Clinton administration in 2000 with strict safety protocols. In 2016, the Obama administration weakened these protections by reducing in-person doctor visits, eliminating the physician prescription requirement, and ending mandatory adverse event reporting. The Biden administration then went further, allowing the abortion pill to be prescribed through telehealth and shipped by mail-leaving women to face serious complications without any medical supervision.

The Restoring Safeguards for Dangerous Abortion Drugs Act would:

• Direct the FDA to reinstate longstanding safeguards for mifepristone use, including prescription by physicians, in-person dispensing in a clinical setting, and in-person safety checkups.
• Create a private right of action for women who suffer bodily injury or harm to mental health from their use of mifepristone to sue individuals and entities that mail the drug- including telehealth providers and pharmacies-in federal or state court for damages.
• Ban foreign companies from importing, mailing, or otherwise bringing mifepristone into the United States.

Cosponsors:Reps. Barry Moore (R-AL), Sheri Biggs (R-SC), Randy Weber (R-TX), and Pat Harrigan (R-NC).

Supporting Organizations:American Family Project, American Principles Project, Eagle Forum, Moms for America, Students for Life, National Right to Life, Ethics and Religious Liberty Commission.

Read more about the bill in the Washington Examiner.